Tag: Mohamed Zaki

AbbVie’s ibrutinib, venetoclax combo succeeds in phase 3 GLOW study

pallavi123- June 13, 2021

AbbVie said that the phase 3 GLOW study in chronic lymphocytic leukemia (CLL) investigating the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax) (I+V) has met ... Read More